Belite Bio Inc
BLTE | NASDAQ
$174.96
+$1.56 (+0.90%)
Sep 22, 2026, 2:09 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -84.21M | -40M | -31.67M | -12.82M | -9.8M | -5.74M |
Interest Income | n/a | 3.74M | 74K | 23K | 5K | 12K |
Pretax Income | -77.61M | -36.14M | -31.62M | -12.65M | -9.67M | -5.75M |
Net Income | -77.61M | -36.14M | -31.63M | -12.65M | -9.67M | -5.75M |
Selling & General & Admin | 38.83M | 10.06M | 6.82M | 3.95M | 2.38M | 2.06M |
Research & Development | 45.38M | 29.94M | 24.84M | 8.87M | 7.42M | 3.69M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 84.21M | 40M | 31.67M | 12.82M | 9.8M | 5.74M |
Interest Expense | n/a | 20K | 25K | 16K | n/a | 21K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 84.21M | 40M | 31.67M | 12.82M | 9.8M | 5.74M |
Income Tax Expense | n/a | 6K | 9K | n/a | n/a | 1K |
Shares Outstanding (Basic) | 33.54M | 30.54M | 26.59M | 19.98M | 24.1M | 9.21M |
Shares Outstanding (Diluted) | 33.54M | 30.54M | 26.59M | 19.98M | 24.1M | 9.21M |
EPS (Basic) | -2.31 | -1.18 | -1.19 | -0.63 | -0.40 | -0.62 |
EPS (Diluted) | -2.31 | -1.18 | -1.19 | -0.63 | -0.40 | -0.62 |
EBITDA | -77.15M | -35.67M | -31.2M | -12.43M | -9.64M | -5.73M |
EBIT | -77.61M | -36.12M | -31.6M | -12.63M | -9.67M | -5.74M |
Depreciation & Amortization | 464K | 449K | 399K | 198K | 30K | 17K |
Add to Watchlist
Select watchlists to add or remove BLTE